Industrializing AI-powered drug discovery: lessons learned from the Patrimony computing platform.

Mickaël GuedjJack SwindleAntoine HamonSandra HubertEmiko DesvauxJessica LaplumeLaura XuerebCéline LefebvreYannick HaudryChristine GabarrocaAudrey AussyLaurence LaigleIsabelle Dupin-RogerPhilippe Moingeon

Published in: Expert opinion on drug discovery (2022)

We report our achievements, but also our challenges in implementing data access and governance processes, building up hardware and user interfaces, and acculturing scientists to use predictive models to inform decisions.

Keyphrases

drug discovery
artificial intelligence
electronic health record
big data
high throughput
quality improvement
global health
machine learning
deep learning